We focused on microbiota members that are underrepresented in the early stages of tumorigenesis and found a mouse strain (Faecalibaculum rodentium PB1) and its human counterpart (Holdemanella biformis) to be underepresented in mouse models or human intestinal advanced adenoma patients. Both strains release short chain fatty acids and control tumor growth in vitro and in vivo.
This is just the beginning of identification of microbiota members that might eventually be used to treat cancer.
Can we treat cancer with the microbiota?
We heard a lot of correlations between microbiota modifications and cancer development, particularly colorectal cancer. Many different species have been associated with the tumor state and some have also demonstrated to be causative as Fusobacterium nucleatum.
Published in
Microbiology
Like
Be the first to like this
Professor, Humanitas University
Follow the Topic
Microbiology
Life Sciences > Biological Sciences > Microbiology
-
Nature Microbiology
An online-only monthly journal interested in all aspects of microorganisms, be it their evolution, physiology and cell biology; their interactions with each other, with a host or with an environment; or their societal significance.
Related Collections
With collections, you can get published faster and increase your visibility.
Progress towards the Sustainable Development Goals
The year 2023 marks the mid-point of the 15-year period envisaged to achieve the Sustainable Development Goals, targets for global development adopted in September 2015 by all United Nations Member States.
Publishing Model: Hybrid
Deadline: Ongoing
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in